Search Results - "FITZGERALD, A. G"

Refine Results
  1. 1

    Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus by Serrano, G E, Lelutiu, N, Rojas, A, Cochi, S, Shaw, R, Makinson, C D, Wang, D, FitzGerald, G A, Dingledine, R

    Published in The Journal of neuroscience (19-10-2011)
    “…Cyclooxygenase-2 (COX-2), a source of inflammatory mediators and a multifunctional neuronal modulator, is rapidly induced in select populations of cortical…”
    Get full text
    Journal Article
  2. 2

    Systemic Biosynthesis of Prostacyclin by Cyclooxygenase (COX)-2: The Human Pharmacology of a Selective Inhibitor of COX-2 by McAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S., Lawson, J. A., Fitzgerald, G. A.

    “…Prostaglandins (PG) are synthesized by two isoforms of the enzyme PG G/H synthase [cyclooxygenase (COX)]. To examine selectivity of tolerated doses of an…”
    Get full text
    Journal Article
  3. 3

    Regulatory Science: What It Is and Why We Need It by FitzGerald, GA

    Published in Clinical pharmacology and therapeutics (01-02-2011)
    “…“Regulatory science” could be interpreted as the “brand” of science pursued by regulatory agencies such as the US Food and Drug Administration (FDA). The…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Effects of celecoxib on major prostaglandins in asthma by Daham, K., Song, W.- L., Lawson, J. A., Kupczyk, M., Gülich, A., Dahlén, S.-E., FitzGerald, G. A., Dahlén, B.

    Published in Clinical and experimental allergy (01-01-2011)
    “…Summary Background Prostaglandin (PG) D2 is a pro‐inflammatory and bronchoconstrictive mediator released from mast cells, and is currently evaluated as a new…”
    Get full text
    Journal Article
  6. 6

    Microsomal prostaglandin E synthase‐1 inhibition in cardiovascular inflammatory disease by Wang, M., Song, W.‐L., Cheng, Y., FitzGerald, G. A.

    Published in Journal of internal medicine (01-05-2008)
    “… Prostaglandins (PGs), particularly PGE2 and prostacyclin (PGI2), are potent mediators of pain and inflammation. Both atherosclerosis and aortic aneurysm…”
    Get full text
    Journal Article Conference Proceeding
  7. 7

    Comparative Impact on Prostanoid Biosynthesis of Celecoxib and the Novel Nonsteroidal Anti-Inflammatory Drug CG100649 by Skarke, C, Alamuddin, N, Lawson, J A, Cen, L, Propert, K J, FitzGerald, G A

    Published in Clinical pharmacology and therapeutics (01-06-2012)
    “…Nonsteroidal anti‐inflammatory drugs (NSAIDs) elevate cardiovascular risk by disrupting cyclooxygenase‐2 (COX‐2)‐dependent biosynthesis of prostacyclin (PGI2)…”
    Get full text
    Journal Article
  8. 8

    Effect of assay specificity on the association of urine 11‐dehydro thromboxane B2 determination with cardiovascular risk by OLSON, M. T., KICKLER, T. S., LAWSON, J. A., MCLEAN, R. C., JANI, J., FITZGERALD, G. A., RADE, J. J.

    Published in Journal of thrombosis and haemostasis (01-12-2012)
    “…Background: Elevated urine 11‐dehydro TXB2, an indicator of persistent thromboxane generation in aspirin‐treated patients, correlates with adverse…”
    Get full text
    Journal Article
  9. 9

    Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles by Barry, O P, Pratico, D, Lawson, J A, FitzGerald, G A

    Published in The Journal of clinical investigation (01-05-1997)
    “…Microparticles are released during platelet activation in vitro and have been detected in vivo in syndromes of platelet activation. They have been reported to…”
    Get full text
    Journal Article
  10. 10

    Isoprostanes: Potential Markers of Oxidant Stress in Atherothrombotic Disease by Patrono, Carlo, FitzGerald, Garret A

    “…Isoprostanes are emerging as a new class of biologically active products of arachidonic acid metabolism of potential relevance to human vascular disease. Their…”
    Get full text
    Journal Article
  11. 11

    Modulation of monocyte-endothelial cell interactions by platelet microparticles by Barry, O P, Praticò, D, Savani, R C, FitzGerald, G A

    Published in The Journal of clinical investigation (01-07-1998)
    “…Platelets, activated by various agonists, produce microparticles (MP) from the plasma membrane, which are released into the extracellular space. Although the…”
    Get full text
    Journal Article
  12. 12

    Modulation of oxidant stress in vivo in chronic cigarette smokers by REILLY, M, DELANTY, N, LAWSON, J. A, FITZGERALD, G. A

    Published in Circulation (New York, N.Y.) (01-07-1996)
    “…Free radical-induced oxidative damage is thought to be involved in the pathogenesis of diseases associated with cigarette smoking. We examined the production…”
    Get full text
    Journal Article
  13. 13

    Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation by McAdam, B F, Mardini, I A, Habib, A, Burke, A, Lawson, J A, Kapoor, S, FitzGerald, G A

    Published in The Journal of clinical investigation (15-05-2000)
    “…To examine the role of cyclooxygenase (COX) isozymes in prostaglandin formation and oxidant stress in inflammation, we administered to volunteer subjects…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Effect of oral prednisone on airway inflammatory mediators in atopic asthma by Dworski, R, Fitzgerald, G A, Oates, J A, Sheller, J R

    “…The mechanism of steroid action in asthma is unknown. Because steroids have effects in vitro on eicosanoid synthesis, we determined the effect of oral…”
    Get more information
    Journal Article
  16. 16

    The origin of electron beam patterning in silver/amorphous chalcogenide bilayers by Fitzgerald, A. G.

    Published in Journal of materials science (01-03-2015)
    “…Previous studies of the effects of the interaction of electron beams with bilayers of amorphous chalcogenides and metals such as silver and copper have shown…”
    Get full text
    Journal Article
  17. 17

    Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man by Wang, Z, Ciabattoni, G, Créminon, C, Lawson, J, Fitzgerald, G A, Patrono, C, Maclouf, J

    “…F2-isoprostanes are prostaglandin (PG) F2-like compounds that are formed in vivo directly by free radical-catalyzed lipid peroxidation. One of the compounds…”
    Get more information
    Journal Article
  18. 18

    COX-2 inhibitors and the cardiovascular system by FitzGerald, G A, Cheng, Y, Austin, S

    Published in Clinical and experimental rheumatology (01-11-2001)
    “…Cyclooxygenase-2 selective inhibitors (coxibs) represent a new class of non steroidal anti-inflammatory drugs that exhibit preference for inhibition of…”
    Get full text
    Journal Article
  19. 19

    Suppression of Thromboxane A2 but Not of Systemic Prostacyclin by Controlled-Release Aspirin by Clarke, Robert J, Mayo, Gail, Price, Patricia, FitzGerald, Garret A

    Published in The New England journal of medicine (17-10-1991)
    “…ASPIRIN has been shown to reduce the incidence of death significantly in patients presenting with unstable coronary vascular disease. 1 2 3 The clinical…”
    Get full text
    Journal Article
  20. 20

    A metabolomic study of adipose tissue in mice with a disruption of the circadian system by Castro, C, Briggs, W, Paschos, G K, FitzGerald, G A, Griffin, J L

    Published in Molecular bioSystems (01-07-2015)
    “…Adipose tissue functions in terms of energy homeostasis as a rheostat for blood triglyceride, regulating its concentration, in response to external stimuli. In…”
    Get more information
    Journal Article